Categories
-
Adhesives
5
Amines
93
Amino Acids
181
Analytical Reagents
673
Antibiotics
252
Bioactive Small Molecules
718
Aroma Chemicals
206
Biochemicals
1014
Boronic Acids
4
Buffers
99
Building Blocks
1782
Carbohydrates
176
Catalysts
99
Chiral Compounds
54
Coccus nucifera oil
0
Detergents
59
Diagnostic Raw Materials
251
Flavours and Fragrance Materials
204
Fluorinated Products
42
Furans
5
Gases in Solution
50
Grignard Reagents
19
HPLC Reagents
8
Imidazoles
17
Indoles
42
Inorganic Chemicals
324
Ion-Pair Reagents
24
Ligands
80
Organics
1307
Oxazoles
3
Peptide Reagents
90
Phenols
44
Picolines
0
Piperazines
10
Pyrazines
2
Pyridines
54
Pyrimidines
30
Quaternary Ammonium salts
44
Reagents
97
Research Organics & Inorganics
753
Salts
284
Sealing Compounds
1
Sherclin
2
Solvents
124
Stains & Indicators
289
Sugars
63
Tailor-made solutions
3
Testing Standards
4
Uncategorised
172
Water Analysis
10
4-Methylumbelliferyl alpha-D-galactopyranoside
(26979173 | 38597-12-5)
| CAS: | 38597-12-5 |
|---|---|
| Molecular Formula: | C16H18O8 |
| Molecular Weight: | 338.31 |
| Availablility: | Inquire for Status |
|---|---|
| Downloads: | | |
| 26979173-100mg | 100mg | £108.90 | |
| 26979173-250mg | 250mg | £185.10 | |
| Bulk Order | |||
| 26979173-100mg | 100mg | €152.50 | |
| 26979173-250mg | 250mg | €259.20 | |
| Bulk Order | |||
| 26979173-100mg | 100mg | $163.40 | |
| 26979173-250mg | 250mg | $277.70 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 26979173 | ||||
| Product Name | 4-Methylumbelliferyl alpha-D-galactopyranoside | ||||
| Categories | Biochemicals Building Blocks Stains & Indicators | ||||
| CAS | 38597-12-5 | ||||
| Molecular Formula | C16H18O8 | ||||
| Molecular Weight | 338.31 | ||||
| Storage Details | -15 to -20 °C | ||||
| Harmonised Tariff Code | 2940000080 |
Product Specification
| Water Content | ≤8.0% | ||||
| Assay (HPLC) | ≥98% | ||||
| Appearance | White solid |
Safety Information
| Pictograms |
|
||||
| Signal word | none | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|